Country 2 Country 4 Cancer (C2C4C) 2025
The 2025 Country 2 Country 4 Cancer ride organised by Bristol Myers Squibb will feature more than 90 of the company's employees cycling in five European countries from 5-22nd September in support of the Union for International Cancer Control (UICC) and selected members to raise funds with the aim of accelerating the fight against cancer and facilitating a better life for cancer patients.
For the 10th year, the 2025 edition of the Country 2 Country 4 Cancer (C2C4C) ride will feature more than 95 Bristol Myers Squibb employees riding in Germany, Switzerland, France, Spain and the United Kingdom, for nearly 2,200 kilometers from 5-22 September.
The 18-day event involves six teams each cycling a three-day segment. This year we celebrate 12 years of C2C4C and riding for patients, a tradition that launched with the inaugural event taking place in the United States in 2014. Since 2016, Bristol Myers Squibb employees in Europe have raised more than USD 3.7 million through the C2C4C ride.
In this 2025 edition, six teams will feature riders participating from 19 countries including Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Netherlands, Norway, Poland, Romania, Spain, Sweden, Switzerland, United Kingdom and United States. The mission of C2C4C is to raise awareness for cancer research and European cancer organisations who are UICC members.
Who are the riders
The participants are novice riders who have committed themselves to five months of intensive training to complete their portion of the ride. Some are cancer survivors, others have witnessed the devastating impact of cancer on friends and family. All are dedicated Bristol Myers Squibb employees who are riding to help raise funds to fight against cancer by supporting European cancer organisations, who are UICC members.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
For more information about Bristol Myers Squibb, visit us at BMS.com or follow them on LinkedIn, Twitter, YouTube, Facebook, and Instagram.
Why raise funds for cancer organisations
Cancer is among the leading causes of death worldwide. In 2022, there were 20 million new cases and 9.7 million cancer-related deaths worldwide, and the number of cases are expected to rise further in the coming decade.
This is why Bristol Myers Squibb chooses to support the UICC and its members in their mission to reduce the global cancer burden, promote greater equity, and ensure that cancer is a priority on the world health and development agenda.
Encourage your colleagues, family and friends to donate as cancer affects us all. Each team rides and raises funds for members of the Union for International Control.
How to support the 2025 C2C4C ride
Segment 1
Country Team – Germany & Czech Republic
Route: Munich, Germany to Boudry, Switzerland
Ride date: Sept. 5-7 2025
UICC members supported:
Segment 2
Country Team – Italy & Switzerland/Austria
Route: Boudry, Switzerland to Nimes, France
Ride date: Sept. 8-10 2025
UICC members supported:
- Italy: Associazione Tumori Toracici Rari
- Switzerland: CANSEARCH
Segment 3
Country Team – Nordics
Route: Nimes, France to Girona, Spain
Ride date: Sept. 11-13 2025
UICC members supported:
- Denmark: SMILfonden
- Finland: Cancer Society of Finland
- Norway: Aktiv mot Kreft
- Sweden: Barncancerfonden
Segment 4
Country Team – Spain/Portugal, Romania & Greece
Route: Girona, Spain to Toulouse, France
Ride date: Sept. 14-16 2025
UICC members supported:
- Spain: Asociación Española Contra el Cáncer (AECC)
- Romania: Asociația MED SAN
- Greece: Hellenic Cancer Foundation - ELLOK
Segment 5
Country Team – France & Poland
Route: Toulouse, France to Paris, France
Ride date: Sept. 17-19 2025
UICC members supported:
-
France: Patients en Réseau
Segment 6
Country Team – United Kingdom/Ireland & Benelux
Route: Paris, France to London, United Kingdom
Ride date: Sept. 20-22 2025
UICC members supported:
-
UK: Maggie's
-
Ireland: Aoibheann’s Pink Tie
-
Belgium: Belgian Foundation against Cancer
-
Netherlands: The Princess Máxima Center Foundation
Quotes
Past editions
Commemorating a decade of Bristol Myers Squibb employees cycling for cancer research
More epic cycling rides in 2022 by BMS to fundraise for UICC members
Inside look at a record fundraise for the 2021 C2C4C ride
Continued support for UICC members despite C2C4C cancellation
Bristol-Myers Squibb team completes fundraising ride across Europe
95 Bristol-Myers Squibb cyclists set off on a 3,600km journey across Europe for cancer research
Bristol-Myers Squibb employees rode over 3,600 km across Europe for cancer patients
Bristol-Myers Squibb employees raise funds for UICC members
Last update
Tuesday 03 June 2025